501 related articles for article (PubMed ID: 23546607)
1. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
2. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study.
Christiansen CF; Christensen S; Mehnert F; Cummings SR; Chapurlat RD; Sørensen HT
Arch Intern Med; 2009 Oct; 169(18):1677-83. PubMed ID: 19822824
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study.
Wu CS; Lin CC; Chang CM; Wu KY; Liang HY; Huang YW; Tsai HJ
J Clin Psychiatry; 2013 Sep; 74(9):918-24. PubMed ID: 24107765
[TBL] [Abstract][Full Text] [Related]
6. Use of Glucocorticoids and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study.
Smit J; Kaasch AJ; Søgaard M; Thomsen RW; Nielsen H; Frøslev T; Schønheyder HC
Mayo Clin Proc; 2016 Jul; 91(7):873-80. PubMed ID: 27289410
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.
Schmedt N; Garbe E
J Clin Psychopharmacol; 2013 Dec; 33(6):753-8. PubMed ID: 24052055
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study.
Johannesdottir SA; Schmidt M; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2012 May; 10(5):815-21. PubMed ID: 22353382
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.
Ishiguro C; Wang X; Li L; Jick S
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779
[TBL] [Abstract][Full Text] [Related]
10. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism after trauma: when do children become adults?
Van Arendonk KJ; Schneider EB; Haider AH; Colombani PM; Stewart FD; Haut ER
JAMA Surg; 2013 Dec; 148(12):1123-30. PubMed ID: 24173244
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.
Bergendal A; Adami J; Bahmanyar S; Hedenmalm K; Lärfars G; Persson I; Sundström A; Kieler H
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):658-66. PubMed ID: 23508885
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism.
Schmidt M; Christiansen CF; Horváth-Puhó E; Glynn RJ; Rothman KJ; Sørensen HT
J Thromb Haemost; 2011 Jul; 9(7):1326-33. PubMed ID: 21592304
[TBL] [Abstract][Full Text] [Related]
14. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
Sundström A; Seaman H; Kieler H; Alfredsson L
BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
[TBL] [Abstract][Full Text] [Related]
15. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study.
Christensen S; Farkas DK; Pedersen L; Miret M; Christiansen CF; Sørensen HT
Neuroepidemiology; 2012; 38(2):76-83. PubMed ID: 22286104
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.
Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT
BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167
[TBL] [Abstract][Full Text] [Related]
18. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
Heinemann LA; Dinger JC; Assmann A; Minh TD
Contraception; 2010 May; 81(5):401-7. PubMed ID: 20399946
[TBL] [Abstract][Full Text] [Related]
19. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study.
Severinsen MT; Johnsen SP; Tjønneland A; Overvad K; Dethlefsen C; Kristensen SR
Eur J Intern Med; 2010 Aug; 21(4):268-72. PubMed ID: 20603033
[TBL] [Abstract][Full Text] [Related]
20. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
